Marian Rewers, MD, PhD
Pediatric Endocrinology
Locations
Practice Locations
Barbara Davis Center for Diabetes Pediatric Clinic - CU Anschutz Medical Campus
303-724-2323
Provider Expertise
Clinical Interest for Patients
screening for type 1 diabetes, early diagnosis, prevention of progression and complications
Care Philosophy
To provides state-of-the-art diabetes care to children and adults with type 1 diabetes
Specialties
- Pediatric Endocrinology ( 1997 )
- Pediatrics ( 1996 )
Conditions & Treatments
-
Child and Teen Health
Juvenile Diabetes
Education & Training
Medical Schools
MD, Poznan University Of Medical Sciences (1981)
Graduate Schools
MPH, University of Pittsburgh (1988)
Internships
Poznan University of Medical Sciences - Poznan, Poland (1984)
Residency Program
Poznan University of Medical Sciences - Poznan, Poland (1984)
Fellowships
University of Pittsburgh Medical Center/Children's Hospital of Pittsburgh (1988)
Professional Memberships
American Diabetes Association, Council on Diabetes in Youth, Member
European Association for the Study of Diabetes, Member
European Diabetes Epidemiology Study Group, Member
Immunology of Diabetes Society, Member
International Diabetes Epidemiology Group, Member
International Society for Pediatric and Adolescent Diabetes, Member
information for referring providers
Referral Contact Phone
(303) 724-2323
Referral Contact Fax
303-724-6779
Clinical Interests for Referring Providers
Children with diabetes, any type
Research Interest for Referring Providers
Dr. Rewers' primary research has been in the area of etiology and epidemiology of type 1 diabetes as well as insulin resistance and cardiovascular complications of diabetes. Dr. Rewers is the principal investigator of large NIH-funded prospective cohort studies: the Diabetes Autoimmunity Study in the Young (NIDDK/NIAID), The Environmental Determinants of Diabetes in the Young (TEDDY), the Coronary Artery Calcification in Type 1 (CACTI) Study (NHLBI), and the Genetic and Environmental Causes of Celiac Disease (NIDDK). In the past, he has directed The Insulin Resistance Atherosclerosis Study (IRAS) and The IRAS Family Study. He serves as the Clinical Investigation & Bioinformatics Core director for the UC Denver Diabetes Endocrinology Research Center (DERC). In 2000, Dr. Rewers initiated a study of early detection of heart disease in 1,400 adult patients with type 1 diabetes and their spouses/partners. The Coronary Artery Calcification in Type 1 (CACTI) Study The study is using electron beam computed tomography in detecting microscopical calcification of coronary arteries. This powerful tool will be used to better define the genetic and metabolic causes of heart disease that is the underlying cause of death in nearly 80% of patients with type 1 diabetes.
